Man, what an example of, "sell the news"! No matter it was good news, lol.
FDA approves generic version of Jazz Pharma's sleep disorder drug BY Reuters — 5:16 PM ET 01/17/2017
Jan 17 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's (JAZZ) drug to treat patients with a medical condition that causes excessive daytime sleepiness. (Reporting by Divya Grover in Bengaluru; Editing by Maju Samuel)
Nice prep- you had to be laying in wait, earlylight.. and pounced like a cheetah!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.